EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Malaria Vaccine Development: Challenges and Prospects

Etefia Etefia, Paul Inyang- Etoh

Medical and Pharmaceutical Journal · 2023

DOI: 10.55940/medphar202225 ↗
AbstractBibliografische Angaben

Abstract

Background: The development of a licensed malaria vaccine has been challenging due to the complex multi-stage life cycle, antigenic variation, and genetic diversity of Plasmodium. Numerous vaccines have been developed for various stages of Plasmodium, including pre-erythrocytic, blood stage, placenta, and transmission-blocking vaccines. However, none of these vaccines are completely effective and have high reactogenicity.Aim: The aim of this review is to examine the challenges and prospects in developing an effective malaria vaccine, with a focus on the development of a multi-stage or multivalent malaria vaccine.Materials and Methods: The authors conducted a review of the literature on malaria vaccine development, focusing on the challenges and prospects of developing an effective malaria vaccine.Results: Efforts are underway to develop a multi-stage or multivalent malaria vaccine (MultiMalVax) that may best target sporozoite development and neutralize merozoites, hepatocytes, and erythrocytes. A thorough understanding of potential vaccine targets and how immunity works is critical to developing a fully effective malaria vaccine.Conclusion: The challenges associated with developing an effective malaria vaccine are significant due to the complex nature of the Plasmodium life cycle. However, the development of a multi-stage or multivalent malaria vaccine offers prospects for overcoming these challenges and developing a fully effective malaria vaccine. A better understanding of potential vaccine targets and how immunity works is crucial in developing an effective vaccine against malaria.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →